author-photo

Daniel Verina

Icahn School of Medicine at Mount Sinai

5

Papers

60

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma:

2021 Therapeutic advances in hematology
Show All
- Source
- Cite
- Save
Citations (3)
Recapturing Disease Response: A Phase 2 Study of Carfilzomib 56 mg/m2 in Patients with Relapsed or Refractory Multiple Myeloma Who Have Progressed on Carfilzomib 27 mg/m2

2019 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma

2017 Blood Advances
Show All
- Source
- Cite
- Save
Citations (46)